Evidence map›Paper›PMID 38227662›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Reverse transcriptase inhibitors prevent liver abscess formation during

Karthik Hullahalli, Katherine G Dailey, Yuko Hasegawa, Welkin E Johnson, Matthew K Waldor

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Karthik HullahalliDepartment of Microbiology, Harvard Medical School, Boston, MA 02115.ORCID 0000-0003-3064-2090
Katherine G DaileyDepartment of Microbiology, Harvard Medical School, Boston, MA 02115.ORCID 0009-0004-7013-0932
Yuko HasegawaDepartment of Microbiology, Harvard Medical School, Boston, MA 02115.
Welkin E JohnsonBiology Department, Boston College, Chestnut Hill, MA 02467.ORCID 0000-0001-5991-5414
Matthew K WaldorDepartment of Microbiology, Harvard Medical School, Boston, MA 02115.ORCID 0000-0003-1843-7000
Brigham and Women's Hospital · USBoston College · US

Funding

Vibrio cholerae intestinal colonization and vaccine developmentR01AI042347 · NIAID · TUFTS UNIVERSITY BOSTON · PI WALDOR, MATTHEW K · 1998 to 2025
$7.3M
Hepatic survival and population dynamics of extraintestinal pathogenic Escherichia coliF31AI156949 · NIAID · HARVARD MEDICAL SCHOOL · PI HULLAHALLI, KARTHIK · 2021 to 2023
$111k
NIAID NIH HHS F31 AI156949NIAID NIH HHS R01 AI042347
6 · The paper itself

Abstract

The presence of bacteria in the bloodstream is associated with severe clinical outcomes. In mice, intravenous inoculation of

Indexed as

Bacterial InfectionsEndogenous RetrovirusesEscherichia coli InfectionsLiver AbscessSepsisAnimalsEscherichia coliMiceNecrosisNucleotidesReverse Transcriptase InhibitorsNucleotidesReverse Transcriptase Inhibitorsbloodstream infectionendogenous retrovirusesliver abscessreverse transcriptase inhibitors

Identifiers

PMID38227662
PMCPMC10823173
OpenAlexW4390904760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.